More News of Interest

GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week

 

Digestive Disease Week® (DDW), taking place May 6 – 9, 2017 in Chicago, Illinois

GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity, announced that new EndoBarrier data will be presented at Digestive Disease Week® (DDW), taking place May 6 – 9, 2017 in Chicago, Illinois.

The schedule for the EndoBarrier presentations at DDW is as follows:

Efficacy and Safety of the EndoBarrier Gastrointestinal Liner on Obesity and Type 2 Diabetes: A Two Center Prospective Study
Date & Time: Saturday, May 6 from 12:00 – 2:00pm UTC
Session: ASGE Presentation │Bariatric
Presenter: Abdulla Alhassani, MD

Augmentation of Meal-Related Symptoms Following Placement of Duodenal-Jejunal Bypass Sleeve is a Potential Mechanism of Action Inducing Weight Loss
Date & Time: Sunday, May 7 from 12:00 – 2:00pm UTC
Session: AGA Presentation │Surgical and Endoscopic Treatment of Obesity
Presenter: Jessica McMaster, Dietician

Improvements of Liver and Glycemic Parameters After Duodenal-Jejunal Bypass Sleeve (DJBS) Insertion
Date & Time: Sunday, May 7 from 12:00 – 2:00pm UTC
Session: ASGE Presentation │Surgical and Endoscopic Treatment of Obesity
Presenter: Gerald Holtmann, MD

Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes
Date & Time: Monday, May 8 from 8:30 – 8:45am UTC
Session: ASGE Presentation │Surgical and Endoscopic Treatment of Obesity
Presenter: Pichamol Jirapinyo, MD

Is Re-Implantation of the Duodenal-Jejunal Bypass Liner Viable?
Date & Time: Monday, May 8 from 10:14 – 10:28am UTC
Session: AGA Presentation │New Bariatric Therapies for Obesity: Surgical and Nonsurgical
Presenter: Jurgen Stein, MD

Latest Posts

Don't Miss